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Data limitations
It is important to note the challenges in researching the recreational use of
cannabis. These challenges include:

gunja
yarndi
weed

Cannabis

mary jane

marijuana
pot

Introduction
Cannabis is the most used illegal drug in the world, used by an estimated 200 million people [1, 2].
Although laws vary between states and territories in Australia, it is illegal to grow, possess, supply,
use or drive under the influence of cannabis [3]. In South Australia and the Australian Capital
Territory (ACT) it is legal to have small amounts of cannabis for personal use [3].
There are three main cannabis products: the dried leaf and bud material (marijuana), cannabis
resin (hashish) and cannabis oil [4]. In Australia, cannabis is known by many slang terms including
gunja, ganja, weed, grass, pot, dope, mull, yarndi, hydro, Mary Jane, and choof [3].
The main chemical in cannabis that affects how the brain works and can cause changes in mood,
behaviour and thoughts is delta9-tetrahydrocannabinol (THC) [2]. Most people use cannabis to feel
the effects of THC, which produces a high, commonly known as being ‘stoned’. Another chemical
found in cannabis is cannabidiol (CBD). CBD does not produce a high like THC [5]. In this Summary,
‘cannabis use’ relates to the use of THC-containing products used for recreational purposes, and
does not discuss the use of cannabis extracts, medicinal cannabis or synthetic cannabis.
Cannabis is mainly smoked, eaten or drunk. Smoking is the most common way of using cannabis,
typically using a pipe, cigarette (joint, blunt) or bong. Hashish and hashish oil are sometimes
added to leaf material and smoked [4]. Tobacco is also often added to cannabis when it is being
smoked [6]. Using cannabis via e-cigarettes or vaporisers is increasing in popularity. Vaping
cannabis can include both vaporising cannabis extracts or dried herb matter [7]. There is a lack of
research regarding recreational smoking of cannabis via e-cigarettes and its consequences [7, 8].
Cannabis can also be added to and consumed in foods such as brownies, and drinks such as tea.
The effects of THC will change depending on how much a person consumes [9]. However, the
amount of THC in cannabis can vary greatly. In the last two decades, advancements in how
cannabis is grown has led to an increase in the strength of cannabis, with the average THC
concentration in cannabis flower products being 20% and some have been identified as being as
high as 60%-80% [2, 10].
6 | Summary of cannabis use among Aboriginal and Torres Strait Islander people
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1.

The difficulty in measuring cannabis use due to the varying rates of THC
concentration, the different ways it can be consumed and the impact of
mixing tobacco with cannabis [11].

2.

The focus of research into cannabis use has been limited, with most studies
looking at either lifetime or past year use of cannabis, meaning that the
frequency, quantity or pattern of use is not assessed.

3.

Some people may not want to disclose their cannabis use because it is
illegal.

4.

Much of the research into cannabis use among Aboriginal communities
has been conducted in remote communities or specific populations such
as people involved with the justice system. This means that findings are
not always generalisable and cannot be considered representative of all
Aboriginal people.

This Summary is based on the Review of cannabis use among Aboriginal and
Torres Strait Islander people. The review summarises the evidence from journal
publications, government reports, national data collections and national surveys
accessed through the HealthInfoNet’s database of publications. Please note that
statistics presented do not always include all states and territories, see sources for
details.

The context of cannabis use among Aboriginal and
Torres Strait Islander people
Historical, social and cultural factors related to cannabis use among
Aboriginal and Torres Strait Islander people
It is important to acknowledge the historical, social and cultural context within which cannabis
use occurs. As a result of both historic and ongoing colonisation; dispossession of land, language
and culture; child removal; and entrenched systemic racism, Aboriginal and Torres Strait Islander
people have greater exposure to social disadvantage. This includes life stressors, traumatic events
and lack of adequate service provision which are all factors associated with alcohol and other
drug (AOD) use and challenges to social and emotional health [12]. This social disadvantage occurs
in the context of racism against Aboriginal and Torres Strait Islander people which still exists, and
happens at a cultural, institutional, and individual level [13-15]. AOD use, including cannabis, can
then also become a risk factor for further marginalisation and ill-health.
These factors are important to consider to:
1. understand prevalence and patterns of cannabis use among Aboriginal and Torres Strait
Islander people
2. review research undertaken and develop appropriate prevention and intervention
approaches.
The challenges which face Aboriginal communities also impact on the available human and
financial resources that can be allocated to reducing cannabis use.
© 2022 Australian Indigenous HealthInfoNet 
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Cannabis use among young people
There is limited data available for first time cannabis use and the lifetime course
of cannabis use. Data from the 2017 Australian Secondary School Alcohol and
Drug Survey (ASSAD) showed that cannabis use starts in school for some young
Aboriginal people. Among the Aboriginal students who responded [20]:
•

19% of those aged 12-15 years reported they had used cannabis

•

43% of those aged 16-17 year reported they had used cannabis.

Cannabis use during pregnancy

Extent of cannabis use among Aboriginal and Torres
Strait Islander people in Australia
Cannabis use prevalence
Even though cannabis is the most used illegal drug in the world, in Australia there is limited data
about cannabis use and its harms among Aboriginal and Torres Strait Islander people. Most of the
current available data are from large national surveys. It is important to note, that these national
level surveys tend to underestimate actual consumption, and adequate sampling from remote
areas is not always possible [16, 17].
The 2018-19 National Aboriginal and Torres Strait Islander Health Survey (NATSIHS) showed that
for respondents aged 15 years and over [18]:

•

•

25% reported using cannabis within the previous month

more males (31%) than females (18%) reported using cannabis

Pregnant women are a priority group for addressing cannabis use because of
the potential harm that it can cause to unborn babies, and the high levels of
cannabis and tobacco being used together. In a study involving 344 mothers of
Aboriginal babies, it was found that around one in five (21%) had used cannabis during pregnancy
[21, 22]
. Similarly, in a study of 257 pregnant Aboriginal women, it was identified that 15% had
smoked cannabis during pregnancy [23]. Almost half of the women in the study did not smoke
cannabis, drink alcohol or smoke tobacco during pregnancy [23]. It is important to note that the
samples from these studies are not representative, and the findings cannot be generalised to all
Aboriginal mothers.

Cannabis use among people involved in the justice
system
Several studies have found high rates of cannabis use among people involved
with the criminal justice system.
Studies among this population have found:
•

46% of Aboriginal males in prison used cannabis daily prior to incarceration [24]

•

20% of males and 26% of females in a study conducted among 419 Aboriginal prisoners
in Queensland were identified as being cannabis dependent [25]

•

79% of justice involved young people (aged 14-17 years) had ever used cannabis and
70% had used in the previous year [26]

•

high levels of cannabis use were noted among Aboriginal police detainees as part of the
Drug Use Monitoring in Australia program, with detection levels ranging from 52% in
Sydney , NSW to 72% in Perth, WA [27].

Polydrug use
•

there was an increase between 2008 and 2018-19 in the proportion of
people who had used cannabis in the last 12 months:
•

from 14% to 25% in remote areas (although reliability of remote
area data is limited)

•

from 18% to 24% in non-remote areas [18, 19].

Cannabis is often used alongside other drugs. Current users of cannabis
have been found to be more likely to be heavy alcohol drinkers and tobacco
smokers than people who do not use cannabis [28, 29]. One study found that while
Aboriginal school students who smoked tobacco were more likely to also smoke cannabis, they
were not more likely to use alcohol [20].
The use of cannabis with tobacco is very common, with a recent study among Aboriginal adults
who identified as smokers finding that 8 in 10 (81%) cannabis smokers also smoked tobacco [30].
Co-use of tobacco with cannabis can have serious health effects, including increasing the risk of
dependence to both substances [31-33].
Cannabis is potentially a risk factor for other illicit drug use [34]. Cannabis use has been shown to be
high in the general Australian community [19] and among Aboriginal people who use illicit drugs [23].
In one study, over half (57%) of Aboriginal participants who used methamphetamine had also used
cannabis in the previous month (a similar proportion to non-Indigenous study participants) [35].
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Movement and coordination
Immediately after use, cannabis can cause impaired movement and coordination
[40, 42]
. This, combined with impaired brain function, can lead to an increased risk
of accidental injury and motor vehicle accidents [43].

Maternal and child health
Emerging evidence in research for the total population suggests that cannabis
use during pregnancy has an impact on maternal and child health. Research in
this area is highly challenging for many reasons including the co-use of tobacco,
under-reporting of cannabis use and complex social determinants.
There is evidence that cannabis use during pregnancy is linked to:

How cannabis use affects health and wellbeing
Cannabis toxicity is considered to be very low and a recent review of cannabis related deaths in
Australia recorded no known cases of cannabis toxicity leading to death. However, there are short
and long term cannabis related harms. Research is still establishing the potential and parameters
for low risk use. Much of the following information is international literature and not specific to
Aboriginal and Torres Strait Islander people.

Physical Health
Airways
Smoking cannabis can expose a person to more tar and certain harmful
chemicals (polycyclic aromatic hydrocarbons) than smoking tobacco [11]. In the
short term, smoking cannabis can cause coughing and throat irritation. Potential
long term effects include ongoing inflammation of the tubes that go to the lungs (chronic
bronchitis), wheezing, and waking up with chest tightness [36-38].
Effects of cannabis on the airways happen without tobacco use but using both cannabis and
tobacco can make the effects worse [11].

Heart and blood vessels
Cannabis use can result in problems to the heart and blood vessels, including
sudden, reduced blood flow to the heart (acute coronary syndrome), blood
vessels tightening and go into spasm (vasospasm) and irregular heartbeat
[39]
(arrhythmias) , particularly among naïve users [40]. It can also lead to an increased risk of chest
pain caused by reduced blood flow to the heart (angina) for those with heart disease [40].
A review of global case reports and studies has highlighted the need to recognise cannabis as a
contributing cause of sudden unexpected death, especially due to issues relating to the heart and
blood flow in the brain [41].

Attention and memory
Cannabis use has been found to have a negative impact on brain function that
persists after someone is no longer ‘stoned’ [37]. Sustained cannabis use has been
found to impact a person’s memory, ability to plan, focus attention, and learn.
Using cannabis over several decades has been found to produce differences in brain function
that may not be completely reversible, particularly for those who started using cannabis in
adolescence [42].
10 | Summary of cannabis use among Aboriginal and Torres Strait Islander people

© 2022 Australian Indigenous HealthInfoNet

•

low birth weight [37, 40, 42, 44, 45]

•

birth complications and increased risk of admission of infant to neonatal intensive care
units [37]

•

potential behavioural problems and developmental delays in children (however, the
evidence is not yet clear, and multiple factors may contribute to this) [46, 47].

Cancer
The relationship between using cannabis and an increased risk of cancer is
not clear cut. It has been found that cannabis smoke can cause cancer [40], but
it is complicated by cannabis and tobacco often being used together. There
is evidence to support that smoking cannabis may increase a person’s risk of developing lung
cancer and, for males, testicular cancer [37].

Sleep
Cannabis use can lead to poor quality sleep [48].

Social and emotional wellbeing (including mental health)
Research has consistently demonstrated a relationship between cannabis use and mental illhealth [37, 40].

Mood disorders
Cannabis use may be a risk factor for depression, especially among people who
use cannabis heavily [37]. This relationship may be stronger among people who
also use tobacco [49]. Cannabis use is also a risk factor for developing bipolar
disorder, with greater risk related to higher levels of use [37]. Cannabis use may worsen symptoms
in those experiencing depression or bipolar disorder [50-52].

Psychosis
Cannabis use is a risk for psychosis (delusions, hallucinations and disordered
thinking) and the diagnosis of schizophrenia [5, 37, 53-55].

© 2022 Australian Indigenous HealthInfoNet 
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Anxiety

Other social emotional and wellbeing harms relating to cannabis use include:

The short-term effects of using cannabis can include anxiety and paranoia
(feelings of suspicion or mistrust of others). In the long term, cannabis use is also
a risk factor for developing anxiety disorders [37].

•

reporting lower overall health and life satisfaction than people who do not use cannabis [36]

•

leaving school early (if used in adolescence) [57]

•

using other illicit drugs [58]

Suicide and self-harm risk

•

heavy alcohol and tobacco use [58].

Cannabis is considered a risk factor for death by suicide [37] and having suicidal
thoughts [56]. Weekly cannabis use has also been linked to a five-fold increase in
self-harm among females [33].

Cannabis dependence
Cannabis dependence is defined as ‘a problematic pattern of cannabis use
leading to clinically significant impairment or distress’ [59]. Dependence is
debilitating and impacts on how people function in everyday life, with significant
time and resources spent on accessing, using and recovering from cannabis use at the expense of
other aspects of their lives. It has been noted that increases in THC content in cannabis are related
to increasing rates of dependence [9].
Around one in ten people who use cannabis will become dependent [60]. The risk of
becoming dependent is greater for people who [37, 40, 49, 61]:
•

started using cannabis in adolescence

•

use cannabis daily or weekly

•

use cannabis with tobacco.

•

anger, aggression or violence

•

headaches

•

nausea.

Table 1 Risk and protective factors for cannabis and AOD use

Risk factors for cannabis use [71]
•
•

Protective factors for cannabis use [72]

Having left school earlier
Being involved with the justice system
as a juvenile.

Risk factors for AOD use [73]

Symptoms of cannabis withdrawal may include [62]:
depressed mood

A small number of studies to date have identified risk and protective factors in relation to
cannabis use. In 2020, a systematic review of the literature looked at the risk and protective
factors for AOD use among Aboriginal and Torres Strait Islander people. The findings from these
studies are outlined in Table 1.

•
•
•
•
•

People who are cannabis dependent may experience withdrawal if they quit or attempt to
quit using cannabis.

•

Risk and protective factors related to cannabis use
among Aboriginal and Torres Strait Islander people

Cannabis related harms among Aboriginal and Torres Strait Islander
people

•
•
•
•
•
•
•
•
•

Never having drunk alcohol
Never smoking cigarettes
Never being diagnosed with anxiety
Having low levels of psychological
distress
Being a parent or caring for a child.

Protective factors for AOD use [73]

Low socio-economic status
High psychological distress
Polydrug use
Being male
Peer pressure
Family or partner substance use
Availability of drugs
Cultural obligations around sharing
Intergenerational trauma.

•
•
•

Supportive environments
Availability of positive role models
Cultural connection.

Patterns of use, such as high rates of cannabis use and use starting at a young age have been
identified as leading to a greater risk of cannabis related harms for Aboriginal and Torres Strait
Islander people. In particular some communities in Northern Australia have identified specific
harms such as high rates of dependence [63], and mental health concerns [64] such as psychosis,
depression and suicide risk [37, 65].
Cannabis use has also been linked to many social harms. Potential harms which have been
identified as being of particular concern by some Aboriginal community members and
researchers in previous studies include [28, 29, 63, 66-70]:
•

the high proportion of income spent on cannabis

•

cannabis use causing relationship issues

•

community violence related to cannabis supply in remote communities

•

declining participation in community life due to cannabis use

•

engagement in the criminal justice system.
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Prevention and treatment for cannabis related harm
Given the lack of overall research into cannabis use among Aboriginal people there is a lack of
evidence about effective responses to harmful cannabis use among Aboriginal people. Given the
lack of evidence, the information below reflects both cannabis specific and broader relevant best
practice approaches to responding to AOD related harm for Aboriginal people.
These principles of best practice include:

Focus on social and emotional wellbeing
Appropriate responses to cannabis use should recognise that substance use is connected to a
holistic sense of health and wellbeing. Families and communities should be involved in any drug
treatment, and treatment and support should be provided to those supporting family members
who may use drugs [74]. To address social and emotional wellbeing there is the need to provide
holistic services that can support people who use cannabis to develop in other life areas [82].

Cultural determination, ownership and leadership
AOD treatment requires community ownership and consultation, without this, interventions
risk being colonising forces [75]. The role of the Aboriginal Community Controlled Health sector is
important to ensure that the needs of the community are properly addressed [76].

Cultural security and cultural responsivity
Culturally secure services for Aboriginal people are essential to best practice. Approaches need
to be embedded in Aboriginal ways of knowing and doing [12, 77]. Culturally safe approaches are
known to result in better outcomes [76].

Appropriate resourcing
Reviews of the Aboriginal AOD treatment sector have highlighted the need for appropriate
planning and resourcing of Aboriginal AOD interventions and recognised the harm of
underfunding and non-recurrent funding [76]. Service providers and intervention approaches need
to be set up to succeed with adequate and continued funding and evaluation [76].

Demand reduction and harm reduction
Health promotion, education and awareness raising

A key component of prevention approaches are school based interventions [80]. These
interventions include programs aimed at educating all children and those targeted at high-risk
individuals and groups. More recent approaches to prevention focus on harm minimisation
messaging and increasing the capacity of young people to make informed choices about drugs
rather than abstinence based approaches [81].

Community interventions
Localised approaches to reducing drug related harm are worth further attention. These
approaches need to be based on community strengths as well as having effective and integrated
strategies [74]. Of particular relevance to cannabis use are approaches which are also linked to
mental health and justice involved populations and include programs which address housing,
family and domestic violence, and education for Aboriginal people [82].

Screening and brief intervention in primary health and antenatal health
Primary health care services and maternal health services are ideally positioned to provide
health promotion, and also screening and brief intervention (with referral if necessary) for those
experiencing or at risk of experiencing substance related harm [76, 83-85].
Considering the high rates of cannabis and tobacco co-use, tobacco intervention and quit
smoking programs may also provide an avenue for effective cannabis interventions, including
health promotion and brief intervention [30].
Given the emerging success of a number of programs targeting tobacco use among Aboriginal
mothers and identification of factors which promote success [86, 87], it is possible that similar
screening and brief intervention approaches that can target cannabis in addition to tobacco are
suited to antenatal settings.

Improving the social determinants
It is widely acknowledged the interventions that target the social determinants of health will
result in reductions in drug use, including cannabis, improve quality of life and reduce the life
expectancy gap between Aboriginal and non-Indigenous Australians [22, 82].

Youth wellbeing and diversion approaches
Preventing young people from starting to use cannabis is an important factor in reducing
cannabis related harm. Due to cannabis use being one component of at-risk behaviour among
young people, holistic approaches which focus on social and emotional wellbeing and other
influencing factors across different areas of a young person’s life are likely to be the most suitable
interventions. One example of this is the Clontarf Academy. The Academy uses Australian Rules
football as a way to engage Aboriginal and Torres Strait Islander boys in school, improve selfesteem, develop skills, and develop prosocial behaviour. Eight out of ten students in the program
finish Year 12, compared to a 45% retention rate for Aboriginal students nationally [88].

Given the prevalence of heavy cannabis use, there is a need for health promotion
materials to support the prevention of cannabis related harm and informed decision making.
However, it is also important to understand that cannabis use may not be a priority harm in many
communities (compared to alcohol and tobacco use, for example) and, in turn, approaches need
to fit within the community needs and wishes [78].
Community knowledge about the harms of cannabis use is generally low [79], so it has been
suggested that investments in locally developed models to improve knowledge around cannabis
use and to inform young people about the harms should be priorities. These should be developed
and distributed in collaboration with communities [79].
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Treatment for harmful cannabis use
Treatment approaches for harmful cannabis use and cannabis dependence
include various counselling approaches, self-help and peer support programs,
the development of social and work skills, residential rehabilitation, and
pharmacotherapy.
Treatment seeking for cannabis use among Aboriginal people is low considering the high rates of
prevalence. It is important to recognise that evidence based treatments are needed and they need
to be easily accessible [89].

Counselling based treatment approaches
Several counselling based clinical approaches have been shown to be useful in treating
cannabis and other drug use in non-Aboriginal populations which have an evidence
base for Aboriginal people. Evidence based approaches to the treatment of cannabis use
include [90, 91]:
•

cognitive behaviour therapy (CBT)

•

motivational enhancement therapy (MET)

•

combination CBT and MET, contingency management (CM)

•

family therapy.

A CBT based approach which has been shown to be acceptable among Aboriginal clients is the
Community Reinforcement Approach (CRA) [92], which uses ideas from CBT and MET to identify
alternatives to AOD use and to develop strategies to reward people for not using substances. CRA
Family Training (CRAFT) works with the client and their family by supporting the family to remove
factors that reinforce substance use and promote factors that support not using substances.
While much of the research to date has focused on the how well certain types of counselling
approaches work, often it is the relationship between the client and the service provider, or
factors other than the therapy which facilitate change [93]. Due to this, a focus on engagement and
relationship building with Aboriginal clients should be viewed with as much importance as the
type of therapy used.

Peer support approaches
Peer support programs, such as SMART Recovery (a mutual support group program), are an
important component of the treatment mix. Peer support programs offer social support and
counselling with peers with lived experience. A recent study investigated the cultural utility
of SMART Recovery for Aboriginal people [94]. Results highlighted the importance of Aboriginal
consultation and the need for a culturally adapted facilitation handbook for SMART Recovery
that included cultural and contextual information and was informed by the lived experience of
Aboriginal people who use drugs.

One study reported on cannabis use outcomes of an Aboriginal program which included a one
to three month residential program that involved holistic treatment incorporating life skills,
case management and therapy within a drug free environment [96]. The majority of clients using
cannabis at intake were still using cannabis at three months after treatment (64%), however
there was a significant reduction in frequency of cannabis use. It was also found that self-harm
and justice involvement had significantly decreased among participants [96]. The results illustrate
the importance of treatment approaches which target a range of determinants of health and are
culturally appropriate.

Pharmacological approaches
There are no current evidence based pharmacological approaches for the treatment of cannabis
use approved in Australia, although a number of recent trials have shown promise [97-100]. Potential
pharmacological approaches include medications to reduce cravings and to address the
symptoms of withdrawal.

Co-morbidity and Mental health services
Considering the relationship between cannabis use and mental ill-health and high rates of
the two occurring together (co-morbidity), there is need for:
•

mental health services to have capacity to address cannabis use

•

drug treatment services to have capacity to address mental health presentations

•

services which address co-morbidity.

There is limited evidence regarding best treatment approaches in cannabis co-morbidity for
Aboriginal people. In a small sample of Aboriginal people in remote communities with AOD and
mental health co-morbidity, brief MET was found to reduce symptoms of mental health and AOD
use disorders [101].

Policy approaches to cannabis use
Cannabis and Health Policy
There are no national policies relating specifically to cannabis use among Aboriginal people.
Community organisations have emphasised the need for a health policy and health response to
cannabis use as holding better potential than current policies, which focus on the legal status of
cannabis use as a deterrent [102].
The health policy frameworks relevant to cannabis use and cannabis related harms
include:
•

the National Drug Strategy (NDS) [103]

•

the now expired National Aboriginal and Torres Strait Islander Peoples’ Drug
Strategy (NATSIDPS) which was a sub strategy of the NDS. Although cannabis is
mentioned in the NATSIPDS, it does not have any associated policies or priorities.

•

the national Closing the Gap targets and outcomes, in which reduction in
substance use is embedded [104].

Residential rehabilitation
Residential rehabilitation is another important component of AOD treatment. Research has
identified that mainstream residential rehabilitation services can be problematic for Aboriginal
people due to cultural differences (different ideas of illness, power imbalances, strict time-tabling)
and a lack of Aboriginal staff [95].
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Approaches to cannabis regulation

Future directions

In Australia cannabis use has traditionally been illegal, yet the regulation of laws around
cannabis varies between states and territories. the three main approaches to governing the
use and supply of cannabis are [105]:
•

full prohibition (use, possession and supply are criminal offences)

•

depenalisation (use and possession are still criminal offences but with lighter
penalties such as education and/or treatment)

•

decriminalisation (use and possession are not criminal, criminal penalties are
replaced with civil penalties, and drug supply remains a criminal offence).

Globally there is a trend towards decriminalising and legalising cannabis use, and changes are
being discussed in Australia. The ACT legalised the possession and cultivation of cannabis as of 31
January 2021 [106] and the legislation of cannabis for recreational use is also being considered in
Victoria [107]. The criminalisation of recreational cannabis use can result in negative consequences,
such as incarceration and fines. It is also resource intensive and can limit people’s willingness to
engage in treatment, prevention and research participation [78, 108].

Selected evidence on fully commercial legal cannabis markets
Australia can learn from countries which have legalised cannabis use, such as the United States
and Canada. Research from the United States and Canada on fully commercialised cannabis
markets has found:
•

large and rapid reductions in cannabis related convictions as a result of cannabis
legalisation [109]

•

young people are often excluded from the legalisation provisions and there appears to
have been some refocussing of police resources towards young cannabis users [110]

•

possible increases in favourable attitudes towards cannabis use and reduced
perceptions of harm.

Evidence that has been collected from these fully commercialised cannabis legalisation models
in North America suggests Australia should be wary about taking a similar approach. Many of the
observed problems of commercial cannabis markets have parallels with the tobacco and alcohol
markets that have caused considerable harm to Australians in general and Aboriginal people in
particular, such as:
•

industry lobbying against public health regulations [111]

•

industry targeting heavy users [112]

•

cannabis retailers tending to locate in areas with more racial and ethnic minority
residents, greater poverty, and more alcohol outlets [113].

Middle ground options
A number of researchers have pointed out that there are a range of ‘middle ground’ policy options
for cannabis between strict prohibition with severe penalties at one end, to full profit-driven
commercialism at the other [114]. These include [115]:
•

home cannabis cultivation

•

cannabis social clubs

•

non-profit cannabis companies

•

cannabis community trusts.
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High prevalence of cannabis use, along with a lack of available resources to
address cannabis related harms, deserves further attention from researchers,
health practitioners and policy makers. There is a need for more detailed
research into cannabis use, its social context of use and related harms among Aboriginal people.
There is also a need for more investment in existing structures and services to better address
cannabis related harms.
Community consultation is required to identify suitable approaches to regulation that minimises
the risks of legislation which criminalises those who use cannabis and legislation based on profitdriven commercialisation of use.

Conclusion
Around the world there has been an increase in the strength of cannabis. This increase
has coincided with a reduction in the perception that cannabis use is harmful. These
developments highlight the need for ongoing research and further investment in health
based approaches to minimise cannabis related harm more broadly. International research
shows that cannabis use, particularly when commencing in adolescence, has potential to
cause harms to the physical and mental wellbeing of individuals and communities.
The current research shows that among Aboriginal people cannabis use prevalence is high,
and among some communities cannabis use is normalised. Of particular concern is the
high prevalence of cannabis use among young Aboriginal and Torres Strait Islander people,
as well as the use of cannabis with tobacco. The co-morbidity of cannabis use and mental
health disorders has been noted in this summary and has implications for the prevention
and treatment of cannabis related harms. Harmful cannabis use is likely to arise from
social disadvantage and perpetuates it. Cannabis is related to a range of social harms
including engagement in the criminal justice system, violence, early withdrawal from
education, and lack of employment.
There is a lack of an evidence base to identify or review best practice approaches in
cannabis prevention and treatment at the individual, family and community level.
There is also a lack of programs and resources with community ownership or co-design,
highlighting a clear need for the development of culturally safe prevention and treatment
resources that can address cannabis related harms. A range of promising opportunities
exist including school based prevention, health promotion resources, and increasing
capacity in mental health and AOD services to better meet the needs of cannabis related
presentations. These opportunities can be maximised if the best practice principles
of focusing on social and emotional wellbeing, cultural safety, self-determination and
adequate resourcing are followed, alongside broader approaches to improving the social
determinants of health.
Cannabis related harms and the prevalence of cannabis use receive limited attention, yet
they are concerning and are an important item on the Aboriginal health agenda.
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